These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 22693310)
1. Imaging of multiple myeloma and related plasma cell dyscrasias. Walker RC; Brown TL; Jones-Jackson LB; De Blanche L; Bartel T J Nucl Med; 2012 Jul; 53(7):1091-101. PubMed ID: 22693310 [TBL] [Abstract][Full Text] [Related]
2. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders. Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739 [TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607 [TBL] [Abstract][Full Text] [Related]
4. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate. Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma. Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787 [TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease. Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575 [TBL] [Abstract][Full Text] [Related]
8. Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy. Catalano L; Pace L; Califano C; Pinto AM; De Renzo A; Di Gennaro F; Del Vecchio S; Fonti R; Salvatore M; Rotoli B Haematologica; 1999 Feb; 84(2):119-24. PubMed ID: 10091409 [TBL] [Abstract][Full Text] [Related]
9. FDG-PET in the evaluation of myeloma in 2012. Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424 [TBL] [Abstract][Full Text] [Related]
10. Imaging in multiple myeloma. Delorme S; Baur-Melnyk A Recent Results Cancer Res; 2011; 183():133-47. PubMed ID: 21509684 [TBL] [Abstract][Full Text] [Related]
11. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS. Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600 [TBL] [Abstract][Full Text] [Related]
12. [The value of fluorodeoxyglucose positron emission tomography in multiple myeloma]. Adam Z; Bolcák K; Stanícek J; Pour L; Hájek R; Krejcí M; Prásek J; Neubauer J; Mareschova Y; Vorlícek J Vnitr Lek; 2006 Mar; 52(3):207-14. PubMed ID: 16722151 [TBL] [Abstract][Full Text] [Related]
13. State-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias. Amini B; Yellapragada S; Shah S; Rohren E; Vikram R Radiol Clin North Am; 2016 May; 54(3):581-96. PubMed ID: 27153790 [TBL] [Abstract][Full Text] [Related]
14. Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology. Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Hillengass M; Wagner B; Hose D; Raab MS; Jauch A; Delorme S; Goldschmidt H; Weber MA; Hillengass J Eur Radiol; 2016 Nov; 26(11):3939-3948. PubMed ID: 26767378 [TBL] [Abstract][Full Text] [Related]
15. Whole-body (18)F-FDG PET identifies high-risk myeloma. Durie BG; Waxman AD; D'Agnolo A; Williams CM J Nucl Med; 2002 Nov; 43(11):1457-63. PubMed ID: 12411548 [TBL] [Abstract][Full Text] [Related]
16. Osteolytic-variant POEMS syndrome: an uncommon presentation of "osteosclerotic" myeloma. Clark MS; Howe BM; Glazebrook KN; Mauermann ML; Broski SM Skeletal Radiol; 2017 Jun; 46(6):817-823. PubMed ID: 28343327 [TBL] [Abstract][Full Text] [Related]
18. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role? Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695 [TBL] [Abstract][Full Text] [Related]
19. [18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods]. Myslivecek M; Bacovský J; Scudla V; Koranda P; Minarík J; Buriánková E; Formánek R; Zapletalová J Klin Onkol; 2010; 23(5):325-31. PubMed ID: 21061682 [TBL] [Abstract][Full Text] [Related]
20. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review. Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]